Journal of Cataract & Refractive Surgery
Volume 35, Issue 4 , Pages 621-624 , April 2009

Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas

Received 3 February 2008 ,Revised 22 October 2008 ,Accepted 26 October 2008.

References 

  1. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97–103
  2. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29:1780–1785
  3. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–627
  4. Wollensak G, Spörl E, Seiler T. Behandlung von Keratoconus durch Kollagenvernetzung [Treatment of keratoconus by collagen cross linking]. Ophthalmologe. 2003;100:44–49
  5. seli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27:590–594
  6. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35–40
  7. Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen; preliminary refractive results in an Italian study. J Cataract Refract Surg. 2006;32:837–845
  8. Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:2035–2040
  9. Kohlhaas M, Spoerl E, Speck A, Schilde T, Sandner D, Pillunat LE. Eine neue Behandlung der Keratektasie nach LASIK durch Kollagenvernetzung mit Riboflavin/UVA-Licht. [A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking]. Klin Monatsbl Augenheilkd. 2005;222:430–436
  10. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008;34:796–801
  11. Wollensak G, Aurich H, Pham D-T, Wirbelauer C. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg. 2007;33:516–521
  12. Wollensak G, Spoerl E, Reber F, Seiler T. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye. 2004;18:718–722
  13. Wollensak G, Spoerl E, Wilsch M, Seiler T. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea. 2004;23:43–49
  14. Wollensak G, Spörl E, Reber F, Pillunat L, Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res. 2003;35:324–328
  15. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26:385–389
  16. Dohlman CH, Hedbys BO, Mishima S. The swelling pressure of the corneal stroma. Invest Ophthalmol. 1962;1:158–162Available at: http://www.iovs.org/cgi/reprint/1/2/158Accessed December 21, 2008
  17. Dohlman CH. Physiology of the cornea: corneal edema. In:  Smolin G,  Thoft RA editor. The Cornea: Scientific Foundations and Clinical Practice. 2nd ed. Boston, MA: Little, Brown and Company; 1987;p. 3–16
  18. Hara T, Maurice DM. Changes in the swelling pressure of the corneal stroma with time, hydration and temperature, determined by a new method. Exp Eye Res. 1972;14:40–48
  19. Maurice DM, Giardini AA. Swelling of the cornea in vivo after the destruction of its limiting layers. Br J Ophthalmol. 1951;35:791–797Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1323849&blobtype=pdfAccessed December 21, 2008
  20. Swartz T, Marten L, Wang M. Measuring the cornea: the latest developments in corneal topography. Curr Opin Ophthalmol. 2007;18:325–333
  21. Wollensak J, Buddecke E. Biochemical studies on human corneal proteoglycans—a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol. 1990;228:517–523

 Dr. Mrochen has a financial interest as the producer of the UV device used in this study. No other author has a financial or proprietary interest in any material or method mentioned.

 Presented at the Third International Cross-Linking Congress, Zurich, Switzerland, December 2007.

PII: S0886-3350(09)00062-5

doi: 10.1016/j.jcrs.2008.10.060

Journal of Cataract & Refractive Surgery
Volume 35, Issue 4 , Pages 621-624 , April 2009

Article Tools

* Image Usage & Resolution